Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi

Science Signaling
Benjamin E HousdenNorbert Perrimon

Abstract

The tuberous sclerosis complex (TSC) family of tumor suppressors, TSC1 and TSC2, function together in an evolutionarily conserved protein complex that is a point of convergence for major cell signaling pathways that regulate mTOR complex 1 (mTORC1). Mutation or aberrant inhibition of the TSC complex is common in various human tumor syndromes and cancers. The discovery of novel therapeutic strategies to selectively target cells with functional loss of this complex is therefore of clinical relevance to patients with nonmalignant TSC and those with sporadic cancers. We developed a CRISPR-based method to generate homogeneous mutant Drosophila cell lines. By combining TSC1 or TSC2 mutant cell lines with RNAi screens against all kinases and phosphatases, we identified synthetic interactions with TSC1 and TSC2. Individual knockdown of three candidate genes (mRNA-cap, Pitslre, and CycT; orthologs of RNGTT, CDK11, and CCNT1 in humans) reduced the population growth rate of Drosophila cells lacking either TSC1 or TSC2 but not that of wild-type cells. Moreover, individual knockdown of these three genes had similar growth-inhibiting effects in mammalian TSC2-deficient cell lines, including human tumor-derived cells, illustrating the power o...Continue Reading

References

Jan 1, 1994·Methods in Cell Biology·L CherbasP Cherbas
Oct 7, 2003·Journal of Biology·A A KigerN Perrimon
Aug 25, 2005·Methods in Molecular Biology·Amy Hin Yan Tong, Charles Boone
Oct 26, 2005·Human Molecular Genetics·David J Kwiatkowski, Brendan D Manning
May 23, 2006·Current Biology : CB·David A GuertinDavid M Sabatini
Sep 29, 2006·The New England Journal of Medicine·Peter B CrinoElizabeth Petri Henske
Sep 30, 2006·Gene Expression Patterns : GEP·Erika A BachGyeong-Hun Baeg
Jan 11, 2008·The New England Journal of Medicine·John J BisslerDavid N Franz
May 10, 2008·The Biochemical Journal·Jingxiang Huang, Brendan D Manning
Jan 30, 2009·Science Signaling·Alena KrejcíSarah J Bray
Apr 28, 2009·American Journal of Respiratory Cell and Molecular Biology·Po-Shun LeeDavid J Kwiatkowski
Nov 5, 2010·The New England Journal of Medicine·Darcy A KruegerDavid Neal Franz
Mar 18, 2011·The New England Journal of Medicine·Francis X McCormackUNKNOWN MILES Trial Group
Nov 1, 2011·Cell·K G GuruharshaSpyros Artavanis-Tsakonas
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Jul 17, 2012·Molecular Cell·Christian C DibbleBrendan D Manning
Oct 3, 2012·Proceedings of the National Academy of Sciences of the United States of America·Daniel F CarlsonScott C Fahrenkrug
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
May 28, 2013·Genetics·Scott J GratzKate M O'Connor-Giles
Jun 25, 2013·Nature Biotechnology·Yanfang FuJeffry D Sander
Jul 6, 2013·Cell Reports·Andrew R BassettJi-Long Liu
Jul 23, 2013·Nature Biotechnology·Patrick D HsuFeng Zhang
Aug 7, 2013·Proceedings of the National Academy of Sciences of the United States of America·Li-En JaoWenbiao Chen
Sep 3, 2013·Nucleic Acids Research·Wataru FujiiKunihiko Naito
Nov 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Xingjie RenJian-Quan Ni
Dec 4, 2013·Molecular Cancer Research : MCR·Andrey A ParkhitkoElizabeth P Henske
Dec 18, 2013·Science·Tim WangEric S Lander
Dec 18, 2013·Science·Ophir ShalemFeng Zhang
Apr 1, 2014·Biochimica Et Biophysica Acta·Sianadh Dunn, Victoria H Cowling
Apr 15, 2014·Nature Biotechnology·Juan A VizcaínoHenning Hermjakob

❮ Previous
Next ❯

Citations

May 24, 2016·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Maximilian Haeussler, Jean-Paul Concordet
Aug 17, 2016·Proceedings of the National Academy of Sciences of the United States of America·Noemie AmmeuxNorbert Perrimon
Sep 9, 2016·Nature Biotechnology·Rodolphe Barrangou, Jennifer A Doudna
Nov 1, 2016·Nature Reviews. Genetics·Benjamin E HousdenNorbert Perrimon
Aug 31, 2017·Fly·Alexandra FranzKonrad Basler
Dec 1, 2017·The Journal of Cell Biology·Suxia RenTao Wang
Dec 1, 2017·Proceedings of the National Academy of Sciences of the United States of America·Benjamin E HousdenNorbert Perrimon
Jul 26, 2018·Future Medicinal Chemistry·Shuaishi Gao, Luhua Lai
Mar 23, 2018·ELife·Pei-Tseng LeeHugo J Bellen
Aug 16, 2017·Proceedings of the National Academy of Sciences of the United States of America·Ben Ewen-CampenNorbert Perrimon
Dec 19, 2018·Wiley Interdisciplinary Reviews. Developmental Biology·Arthur LuhurAndrew C Zelhof
Dec 24, 2019·Current Protocols in Molecular Biology·Justin A BoschStephanie E Mohr
Dec 12, 2019·G3 : Genes - Genomes - Genetics·Chiao-Lin ChenNorbert Perrimon
Aug 21, 2020·Genes & Development·Bing YangKatherine McJunkin
Aug 8, 2015·Genetics·Shuailiang LinNorbert Perrimon
Sep 3, 2016·Cold Spring Harbor Protocols·Benjamin E HousdenNorbert Perrimon
Jan 12, 2017·Mediators of Inflammation·Danilo Figueiredo SoaveMara Rúbia Nunes Celes
Dec 13, 2017·Proceedings of the National Academy of Sciences of the United States of America·Samuel LessardMatthew C Canver
Jan 6, 2018·Genetics·Ethan BierJill Wildonger
Jul 22, 2020·Nature Neuroscience·Jesse Isaacman-BeckThomas R Clandinin
Feb 26, 2016·The Journal of Biological Chemistry·Ben-Zion Shilo
Apr 13, 2018·Interdisciplinary Sciences, Computational Life Sciences·Yingbo CuiShaoliang Peng
Apr 11, 2019·ELife·Loïc BinanSantiago Costantino
Jul 13, 2018·Nature Biomedical Engineering·Jennifer ListgartenNicolo Fusi
Oct 16, 2019·Cell Communication and Signaling : CCS·Yong FengZhenfeng Duan
Aug 27, 2016·ELife·Huajin WangRobert V Farese
Oct 22, 2017·The FEBS Journal·Massimiliano MazzoneAlessandra Castegna
Oct 3, 2019·Science Signaling·Hilary E NicholsonWilliam G Kaelin

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.